Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

ARDX.US Logo

ARDX.US - Current Price

$7.36

Company Information

▼
Company Name
Ardelyx Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US0396971071
CIK: 0001437402
CUSIP: 039697107
Currency: USD
Full Time Employees: 395
Phone: 510 745 1700
Website: https://www.ardelyx.com
Fiscal Year End: December
IPO Date: Jun 19, 2014
Description:

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Address:

400 Fifth Avenue, Waltham, MA, United States, 02451

Directors & Officers

▼
Name Title Year Born
Mr. Michael G. Raab President, CEO & Director 1965
Ms. Elizabeth A. Grammer Esq. General Counsel 1964
Dr. Laura A. Williams M.D., M.P.H. Chief Patient Officer & Interim Chief Medical Officer 1963
Mr. Mike Kelliher Chief Business Officer 1977
Ms. Sue Hohenleitner Chief Financial Officer 1970
Mr. Joseph Reilly Senior VP of Finance & Principal Accounting Officer 1974
Ms. Caitlin Lowie Vice President of Corporate Communications & Investor Relations NA
Mr. James P. Brady Chief Human Resources Officer NA
Mr. Eric Duane Foster Chief Commercial Officer 1975
Dr. John Bishop Ph.D. Chief Technical Operations Officer NA

Shares Statistics

▼
Shares Outstanding: 242.97M
Shares Float: 234.60M
% Insiders: 275.10%
% Institutions: 6,736.60%
Short % Float: 11.42%

Valuation Metrics

▼
Enterprise Value: $1.75B
Trailing P/E: 0.00
Forward P/E: 61.35

Financial Highlights

▼
Market Cap: $1.79B
EBITDA: $-35.30M
PEG Ratio: $-0.08
Book Value: $0.64
Earnings/Share: $-0.23
Profit Margin: -14.20%
Operating Margin: 4.23%
ROA (TTM): -5.55%
ROE (TTM): -36.18%
Revenue (TTM): $398.23M
Revenue/Share (TTM): $1.66
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 12.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.02 N/A 10,000.00%
Sep 30, 2025 0.00 -0.06 N/A 9,297.01%
Jun 30, 2025 -0.08 -0.12 N/A 3,437.24%
Mar 31, 2025 -0.17 -0.15 N/A -1,333.33%
Dec 31, 2024 0.02 0.00 N/A 295,714.29%
Sep 30, 2024 0.00 -0.05 N/A 9,320.00%
Jun 30, 2024 -0.07 -0.11 N/A 3,636.36%
Mar 31, 2024 -0.11 -0.15 N/A 2,666.67%
Dec 31, 2023 -0.12 -0.09 N/A -3,333.33%
Sep 30, 2023 0.03 -0.11 N/A 12,727.27%
Jun 30, 2023 -0.08 -0.11 N/A 2,727.27%
Mar 31, 2023 -0.13 -0.10 N/A -3,000.00%
Dec 31, 2022 0.06 -0.02 N/A 40,000.00%
Sep 30, 2022 -0.14 -0.17 N/A 1,764.71%
Jun 30, 2022 -0.19 -0.19 N/A 0.00%
Mar 31, 2022 -0.21 -0.22 N/A 454.55%
Dec 31, 2021 -0.31 -0.30 N/A -333.33%
Sep 30, 2021 -0.42 -0.35 N/A -2,000.00%
Jun 30, 2021 -0.45 -0.37 N/A -2,162.16%
Mar 31, 2021 -0.34 -0.33 N/A -303.03%
Dec 31, 2020 -0.32 -0.26 N/A -2,307.69%
Sep 30, 2020 -0.20 -0.28 N/A 2,857.14%
Jun 30, 2020 -0.28 -0.26 N/A -769.23%
Mar 31, 2020 -0.25 -0.25 N/A 0.00%
Dec 31, 2019 -0.27 -0.32 N/A 1,562.50%
Sep 30, 2019 -0.37 -0.37 N/A 0.00%
Jun 30, 2019 -0.41 -0.38 N/A -789.47%
Mar 31, 2019 -0.42 -0.39 N/A -769.23%
Dec 31, 2018 -0.45 -0.41 N/A -975.61%
Sep 30, 2018 -0.39 -0.41 N/A 487.80%
Jun 30, 2018 -0.42 -0.44 N/A 454.55%
Mar 31, 2018 -0.36 -0.46 N/A 2,173.91%
Dec 31, 2017 0.21 -0.41 N/A 15,121.95%
Sep 30, 2017 -0.44 -0.54 N/A 1,851.85%
Jun 30, 2017 -0.54 -0.64 N/A 1,562.50%
Mar 31, 2017 -0.59 -0.67 N/A 1,194.03%
Dec 31, 2016 -0.66 -0.66 N/A 0.00%
Sep 30, 2016 -0.65 -0.74 N/A 1,216.22%
Jun 30, 2016 -0.83 -0.75 N/A -1,066.67%
Mar 31, 2016 -0.70 -0.66 N/A -606.06%
Dec 31, 2015 -0.65 -0.81 N/A 1,975.31%
Sep 30, 2015 -0.70 -0.48 N/A -4,583.33%
Jun 30, 2015 0.42 0.09 N/A 36,666.67%
Mar 31, 2015 -0.19 0.01 N/A -200,000.00%
Dec 31, 2014 -0.21 0.02 N/A -115,000.00%
Sep 30, 2014 -0.21 0.09 N/A -33,333.33%
Jun 30, 2014 0.18 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $64.93M $N/A $435.75M $262.47M $173.29M
2023-12-31 $21.47M $N/A $297.58M $130.76M $166.82M
2022-12-31 $96.14M $N/A $190.07M $91.74M $98.33M
2021-12-31 $72.43M $N/A $149.91M $67.30M $82.62M
2020-12-31 $91.03M $N/A $201.56M $75.45M $126.11M
2019-12-31 $181.13M $N/A $259.78M $73.13M $186.66M
2018-12-31 $78.77M $N/A $183.33M $67.52M $115.81M
2017-12-31 $75.38M $N/A $157.90M $18.59M $139.31M
2016-12-31 $74.60M $N/A $213.13M $19.98M $193.15M
2015-12-31 $107.00M $N/A $116.95M $8.05M $108.90M
2014-12-31 $107.29M $N/A $113.41M $52.73M $60.68M
2013-12-31 $34.44M $N/A $42.90M $50.23M $-7.32M
2012-12-31 $32.90M $N/A $37.88M $39.12M $-1.24M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 26, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Jun 16, 2025 N/A N/A N/A N/A N/A N/A
Jun 09, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 02, 2025 N/A N/A N/A N/A N/A N/A
May 02, 2025 N/A N/A N/A N/A N/A N/A
Apr 04, 2025 N/A N/A N/A N/A N/A N/A
Mar 07, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist